Interim report
Page 1
Q3 21 QUARTERLY REPORT DIGNITANA Clinically superior scalp cooling Moving toward cash flow positivity in 2022 with accelerating reimbursement activity NOVEMBER 18 • 2021
Loading workspace
Q3 21 QUARTERLY REPORT DIGNITANA Clinically superior scalp cooling Moving toward cash flow positivity in 2022 with accelerating reimbursement activity NOVEMBER 18 • 2021
Your watchlist and earnings event details are available after you sign in.